Segmental amplification of 11q23 region identified by flourescence in situ hybridization in four patients with myeloid disorders: A review

Cancer Genetics and Cytogenetics

Volumn 126, Issue 2, 2001, Pages 139-146

  Reddy, K S ^a   Parsons, L ^a   Mak, L ^a   Dighe, P ^b   Saphner, T ^c   Crow, M K ^d   Scott, M ^e  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^b Stockton Hematology Oncology Medical Group Inc   (United States)

^c Green Bay Oncology   (United States)

^d Diagnostic Clinic of Houston   (United States)

^e Indian River Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; HYDROXYUREA; IDARUBICIN; RITUXIMAB; TAMOXIFEN;

ACUTE MYELOBLASTIC LEUKEMIA; CASE STUDY; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CYTOGENETICS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MAPPING; HUMAN; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0035870781     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00406-4     Document Type: Article

References (18)

1. Tanaka K., Arif M., Eguchi M., Kyo T., Dohy H., Kamada N. Frequent jumping translocations of chromosomal segments involving ABL oncogene alone or in combination with CD3-MLL genes in secondary leukemias. Blood. 89:1997;596-600.
2. Li Y.P. Double minutes in acute myeloid leukemia. Int J Cancer. 32:1983;955-959.
3. Mohamed A.N., Macoska J.A., Kallioniemi A., Kallioniemi O.P., Waldman F., Ratanatharathorn V., Wolman S.R. Extrachromosomal gene amplification in acute myeloid leukemia. characterization by metaphase analysis, comparative in situ hybridization, and semi-quantitative PCR Genes Chromosom Cancer. 8:1993;185-189.
4. Ariyama Y., Fukuda Y., Okuno Y., Seto M., Date K., Abe T., Nakamura Y., Inazawa J. Amplification on double minute chromosomes and partial tandem duplication of the MLL gene in leukemic cells of a patient with acute myelogenous leukemia. Genes Chromosomes Cancer. 23:1998;267-272.
5. Avet-Loiseau H., Gordon C., Li J.-Y., Daviet A., Mellerin M.-P., Talmant P., Harousseau J.-L., Bataille R. Amplification of the 11q23 in acute myeloid leukemia. Genes Chromosom Cancer. 26:1999;166-170.
6. Streubel B., Valent P., Jager U., Edelhauser M., Wandt H., Wagner T., Buchner t, lechner K., Fonatsch C. Amplification of the MLL gene on double minutes, a homogenously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chromosom Cancer. 27:2000;380-386.
7. Felix C.A., Megonigal M.D., Chervinsky D.S., Leonard D.G.B., Tsuchida N., Kakati S., Block A.M.W., Fisher J., Grossi M., Salhany K.I., Jani-Sait S.N., Aplan P.D. Association of germline p53 mutation with MLL segmental jumping translocation in treatment-related leukemia. Blood. 91:1998;4451-4456.
8. Allen R.J., Smith S.D., Moldwin R.L., Lu M.M., Giordno L., Vignon C., Beau M.M., Rowley J.D., Zeleznik-Le N. Establishment and characterization of a megakaryoblast cell line with amplification of MLL. Leukemia. 12:1998;1119-1127.
9. Cuthbert G., McCullough S., Finney R., Breese G., Brown N. Jumping translocation at 11q23 with MLL gene rearrangement and interstitial telomeric sequences. Genes Chromosom Cancer. 24:1999;295-298.
10. Reddy K.S., Parsons L., Wang S., Mak L., Dighe P., Yu T.L. An AML-5a patient with segmental 11q23-MLL region identified using FISH. Can Genet Cytogenet. 118:2000;48-51.
11. Schnittger S., Kinkelin U., Schoch C., Heinecke A., Hasse D., Haferlach T., Buchner T., Wormann B., Hiddemann W., Griesinger F. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavourable subset of AML. Leukemia. 14:2000;796-804.
12. Caligiuri M.A., Strout M.P., Lawrence D., Arthur D.C., Baer M.R., Yu F., Knuutila S., Mrozek K., Oberkircher A.R., Marcucci G., de la Chapelle A., Elonen E.E., Block A.W., Rao P.N., Herzig G.P., Powell B.L., Ruutu T., Schiffer C.A., Bloomfield C.D. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res. 58:1998;55-59.
13. Yu M., Honoki K., Andersen J., Paietta E., Nam D.K., Yunis J.J. MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype. Leukemia. 10:1996;774-780.
14. Strout M.P., Marcucci G., Bloomfield C.D., Caligiuri M.A. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc Natl Acad Sci. 95:1998;2390-2395.
15. Flannery J.T., Boice J.D. Jr., Devesa S.S., Kleinerman R.A., Curtis R.E., Fraumeni J.F. Jr. Natl Cancer Inst Monogr. 68:1995;13-24.
16. Donaldson S.S., Hancock S.L. Second cancers after Hodgkin's disease in childhood. N Engl J Med. 334:1997;792-793.
17. Wolden S.L., Lamborn Kl Cleary S.F., Tate D.J., Donalson S.S. Second cancers following pediatric Hodgkin's disease. J Clin Oncol. 16:1998;536-544.
18. Travis L.B., Curtis R.E., Boice J.D. Jr., Platz C.E., Hankey B.F., Fraumeni J.F. Jr. Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Res. 56:1996;1564-1570.